Paragon Bioservices, Inc.
Lynn Betts is currently the Manager - Quality Control and Project Manager at Paragon Bioservices, Inc. Lynn has a strong background in project management, quality control, and process development in the pharmaceutical and biopharmaceutical industries. Lynn has also held significant roles at companies such as Cambrex BioScience and Mission Critical Enterprises, showcasing a diverse range of experience in project management and quality control. Lynn holds a Bachelor of Science degree in Biology from the University of Pittsburgh.
This person is not in any teams
Paragon Bioservices, Inc.
With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs.